| human | Q5 |
| P734 | family name | Curtis | Q12787162 |
| Curtis | Q12787162 | ||
| Curtis | Q12787162 | ||
| P106 | occupation | researcher | Q1650915 |
| Q38522496 | A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy. |
| Q35651744 | Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. |
| Q72954534 | Acute nonlymphocytic leukemia after small-cell lung cancer |
| Q34173479 | Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study |
| Q91562569 | Ambient ultraviolet radiation and major salivary gland cancer in the United States |
| Q80889284 | Assessment of delayed reporting of mycosis fungoides and Sezary syndrome in the United States |
| Q39315948 | Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting |
| Q90968792 | Association of Breast Cancer Risk After Childhood Cancer With Radiation Dose to the Breast and Anthracycline Use: A Report From the Childhood Cancer Survivor Study |
| Q90664127 | Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era |
| Q49964664 | Association of Treatment for Hodgkin Lymphoma With Estrogen Receptor Status of Subsequent Breast Cancers |
| Q90786160 | Association of lifestyle and clinical characteristics with receipt of radiotherapy treatment among women diagnosed with DCIS in the NIH-AARP Diet and Health Study |
| Q34721817 | Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma |
| Q69683348 | Bladder cancer after chemotherapy for non-Hodgkin's lymphoma |
| Q34611664 | Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies |
| Q58411256 | Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease |
| Q35847689 | Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors |
| Q34067111 | Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group |
| Q53724617 | Cancer registration in Connecticut and the study of multiple primary cancers, 1935-82. |
| Q99568572 | Cause-Specific Mortality Following Initial Chemotherapy in a Population-Based Cohort of Patients With Classical Hodgkin Lymphoma, 2000-2016 |
| Q89850827 | Cause-specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000-2016 |
| Q40163048 | Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology |
| Q34611659 | Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers |
| Q33838842 | Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer |
| Q70065632 | Evaluation of AJC stomach cancer staging using the SEER population |
| Q30538788 | Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008. |
| Q34554733 | Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study |
| Q40809137 | Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12. |
| Q37426719 | Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States. |
| Q37037303 | Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome |
| Q30574756 | Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site |
| Q73042220 | Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation |
| Q39419020 | Increased pancreatic cancer risk following radiotherapy for testicular cancer |
| Q35677701 | Increased stomach cancer risk following radiotherapy for testicular cancer |
| Q41508669 | Introduction to the study of multiple primary cancers |
| Q44005671 | Late effects of treatment for childhood Hodgkin's disease |
| Q54009687 | Leukemia following chemotherapy for breast cancer. |
| Q53456824 | Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma. |
| Q38517475 | Leukemia risk following radiotherapy for breast cancer |
| Q72019222 | Lung cancer after Hodgkin's disease |
| Q43853157 | Lung cancer after treatment for Hodgkin's disease: focus on radiation effects |
| Q43878525 | Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease |
| Q42371170 | Malignant neoplasms associated with cancer of the ampulla of Vater |
| Q48452116 | Merkel cell carcinoma and multiple primary cancers |
| Q30469657 | Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States |
| Q36989325 | Multiple primary cancers in Connecticut, 1935-82 |
| Q52719122 | Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival. |
| Q34528330 | Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. |
| Q38462204 | New malignancies following childhood cancer in the United States, 1973-2002. |
| Q73358721 | New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia |
| Q34250016 | Pancreatic cancer risk after treatment of Hodgkin lymphoma |
| Q30528194 | Patterns of bone sarcomas as a second malignancy in relation to radiotherapy in adulthood and histologic type |
| Q37029350 | Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004. |
| Q33992357 | Pooling prospective studies to investigate the etiology of second cancers |
| Q34162911 | Prediction of the location and size of the stomach using patient characteristics for retrospective radiation dose estimation following radiotherapy |
| Q34914474 | Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries |
| Q81014001 | Prostate radiotherapy is associated with second cancers in many organs, not just the colorectum |
| Q98665690 | Racial and ethnic differences in risk of second primary cancers among prostate cancer survivors |
| Q37318317 | Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer |
| Q44508827 | Radiation dose to the esophagus from breast cancer radiation therapy, 1943-1996: an international population-based study of 414 patients |
| Q40108206 | Radiotherapy for ductal carcinoma in situ and risk of second non-breast cancers |
| Q95806285 | Re: Lung cancer risk and radiation dose among women treated for breast cancer |
| Q72138140 | Relationship of leukemia risk to radiation dose following cancer of the uterine corpus |
| Q46474774 | Response:Solid cancers after allogeneic hematopoietic cell transplantation. |
| Q36090959 | Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma. |
| Q37201899 | Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation |
| Q36689790 | Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma. |
| Q90953715 | Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation |
| Q91525943 | Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes |
| Q58411595 | Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer |
| Q96609317 | Risk of Second Primary Bone and Soft-Tissue Sarcomas Among Young Adulthood Cancer Survivors |
| Q34250220 | Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy |
| Q42923398 | Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma |
| Q68137055 | Risk of leukemia after chemotherapy and radiation treatment for breast cancer |
| Q77939269 | Risk of leukemia after platinum-based chemotherapy for ovarian cancer |
| Q70930642 | Risk of leukemia associated with the first course of cancer treatment: an analysis of the Surveillance, Epidemiology, and End Results Program experience |
| Q72198411 | Risk of leukemia following treatment for non-Hodgkin's lymphoma |
| Q73023273 | Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study |
| Q44717416 | Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer |
| Q28392833 | Risk of non-Hodgkin lymphoma after radiotherapy for solid cancers |
| Q33844660 | Risk of radiation-related salivary gland carcinomas among survivors of Hodgkin lymphoma: a population-based analysis |
| Q43498951 | Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program |
| Q69565894 | Risk of second malignancy after cancers of the renal parenchyma, renal pelvis, and ureter |
| Q69961841 | Risk of second malignancy after cutaneous T-cell lymphoma |
| Q92299816 | Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015 |
| Q74711635 | Risk of subsequent cancer following breast cancer in men |
| Q88796964 | Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2014 |
| Q92153959 | Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study |
| Q36408560 | Risk of treatment-related esophageal cancer among breast cancer survivors |
| Q42553649 | Risks of non-Hodgkin's lymphoma, multiple myeloma, and leukemia associated with common medications |
| Q58411329 | Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years |
| Q93675626 | Second cancer following cancer of the female genital system in Connecticut, 1935-82 |
| Q71093678 | Second cancers after adjuvant tamoxifen therapy for breast cancer |
| Q58411447 | Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence |
| Q44576715 | Second cancers among long-term survivors of non-Hodgkin's lymphoma |
| Q70118111 | Second cancers following non-Hodgkin's lymphoma |
| Q52671549 | Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. |
| Q72052306 | Second cancers following radiotherapy for cervical cancer |
| Q72240881 | Second cancers in patients with Ewing's sarcoma |
| Q42607910 | Second cancers in patients with chronic lymphocytic leukemia |
| Q72516797 | Second malignancies after testicular cancer |
| Q34488720 | Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype |
| Q71006093 | Second malignant neoplasms among long-term survivors of ovarian cancer |
| Q71085906 | Second primary cancers after vulvar and vaginal cancers |
| Q36047579 | Second primary malignancies following salivary gland cancers |
| Q26996120 | Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationship |
| Q33620015 | Second solid cancers after radiotherapy for breast cancer in SEER cancer registries |
| Q37082013 | Solid cancers after allogeneic hematopoietic cell transplantation |
| Q48760643 | Solid cancers after bone marrow transplantation |
| Q39001880 | Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects |
| Q37165088 | Stomach cancer risk after treatment for hodgkin lymphoma |
| Q93675634 | Summary: multiple primary cancers in Connecticut, 1935-82 |
| Q40529469 | Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis |
| Q36487523 | The association between cancer and amyotrophic lateral sclerosis |
| Q38214321 | The rising incidence of second cancers: patterns of occurrence and identification of risk factors for children and adults |
| Q36328710 | The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status |
| Q43523794 | The risk of developing second cancers among survivors of childhood soft tissue sarcoma |
| Q58411442 | Treatment-Associated Leukemia Following Testicular Cancer |
Search more.